The information set forth under this "Item 2.02. Results of Operations and Financial Condition," including the exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Attached as Exhibit 99.1 is a copy of a press release of Cyclacel Pharmaceuticals, Inc. (the "Company"), dated November 12, 2012, announcing certain financial results for the third quarter ended September 30, 2012.

The Company conducted a conference call to review its financial results on Monday, November 12, 2012, at 4:30 p.m., Eastern Time. To access the archived conference call, please dial (877) 493-9121 in the US and Canada or (973) 582-2750 internationally, and use 69718892 as the access code. For the archived webcast, please visit the Corporate Presentations page on the Company's website at www.cyclacel.com. The webcast will be archived for 90 days and the audio replay for seven days from the date of the conference call.

(d) Exhibits.

Exhibit
Number                                 Description

99.1      Press release announcing financial results for the third quarter ended
          September 30, 2012, dated November 12, 2012.